Clobazam is a generic drug that’s prescribed for seizures caused by Lennox-Gastaut syndrome (LGS) in adults and some childre n. The medication is available as the brand-name drugs Onfi and Sympazan.

On December 3, 2013, the US Food and Drug Administration (FDA) issued a drug safety communication warning of "rare but serious" skin reactions from the antiseizure drug clobazam. [1] These included ...

The antiseizure drug clobazam (Onfi, Lundbeck) can trigger rare but potentially fatal skin reactions, the US Food and Drug Administration (FDA) announced today. For clobazam, the skin reactions to ...

New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy SYMPAZAN is the only FDA-approved ...

Review the side-effects of Clobazam as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

COPENHAGEN, Dec 6 (Reuters) - Danish drugmaker H Lundbeck said it got positive results in a Phase 3 trial of its candidate drug clobazam in treating seizures associated with Lennox-Gastaut syndrome.

“At present, there is insufficient evidence to inform clinical practice regarding clobazam monotherapy in focal or generalized seizures,” concluded the authors, adding “There is a definite need for ...

Discover comprehensive details about Clobazam, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Patients prescribed levetiracetam or clobazam should be informed about the risk of DRESS. The Food and Drug Administration (FDA) has issued a safety alert regarding the risk of DRESS (drug reaction ...

(CBS) The drug clobazam (Onfi) has been approved by the FDA for the treatment of a rare but severe form of epilepsy in adults and in children age two or older. "Lennox-Gastaut syndrome is a severe ...

Phase 3 clobazam trial gets good results treating seizures Company repeats will file application with FDA by year-end COPENHAGEN, Dec 6 (Reuters) - Danish drugmaker Lundbeck has got positive results ...